how much weight can you lose with retatrutide The next big shift in obesity care may not be surgery — it may be a weekly shot. Retatrutide, an investigational triple-action medicine, showed 28.3% average body-weight loss over 80 weeks in VisualAbstract: Retatrutide reduces body weight

Wegovy is available for obesity under NHS specialist criteria

Total: 49 days door-to-door for compounded products

doi: 10.1161/01.RES.0000267723.65696.4a 177 PotenteMGhaeniLBaldessariDMostoslavskyRRossigLDequiedtFet al

For Research Use Only Summary Retatrutide is a next-generation investigational triple-receptor peptide researched for its interaction with GLP-1, GIP, and glucagon receptor pathways involved in metabolism, appetite regulation, energy expenditure, and body-composition signaling

GLP-1s, Gut Motility & IBS GLP-1 medications are increasingly being used for weight management and blood sugar control, but their effects go well beyond appetite

The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis